100 related articles for article (PubMed ID: 139840)
1. [Functional activity of cytolytic T lymphocytes in the rejection of tumor target cells].
Brunner KT; Cerottini JC
Ann Immunol (Paris); 1977; 128(1-2):473-83. PubMed ID: 139840
[TBL] [Abstract][Full Text] [Related]
2. Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. I. Preferential reactivity of in vitro generated secondary CTL with syngeneic tumor cells.
Plata F; Jongeneel V; Cerottini JC; Brunner KT
Eur J Immunol; 1976 Nov; 6(11):823-9. PubMed ID: 187429
[TBL] [Abstract][Full Text] [Related]
3. Functional activity in vivo of effector T cell populations. III. Protection against Moloney murine sarcoma virus (M-MSV)-induced tumors in T cell deficient mice by the adoptive transfer of a M-MSV-specific cytolytic T lymphocyte clone.
Cerundolo V; Lahaye T; Horvath C; Zanovello P; Collavo D; Engers HD
Eur J Immunol; 1987 Feb; 17(2):173-8. PubMed ID: 3030766
[TBL] [Abstract][Full Text] [Related]
4. Primary and secondary in vitro generation of cytolytic T lymphocytes in the murine sarcoma virus system.
Plata F; Cerottini JC; Brunner KT
Eur J Immunol; 1975 Apr; 5(4):227-33. PubMed ID: 185057
[TBL] [Abstract][Full Text] [Related]
5. Suppressor T cells regulate the cytolytic T lymphocyte response to syngeneic tumors induced by murine sarcoma virus (MSV) in the mouse.
Plata F; MacDonald HR; Shain B
J Immunol; 1979 Aug; 123(2):852-60. PubMed ID: 156765
[TBL] [Abstract][Full Text] [Related]
6. Cell-mediated immunity to antigens associated with murine sarcoma virus-induced tumors: augmentation of cytolytic T lymphocyte activity by successive specific and nonspecific stimulation in vitro.
Ryser JE; Cerottini JC; Brunner KT
Eur J Immunol; 1979 Mar; 9(3):179-84. PubMed ID: 221224
[TBL] [Abstract][Full Text] [Related]
7. Characterization of effector lymphocytes associated with immunity to murine sarcoma virus (MSV) induced tumors. I. Physical properties of cytolytic T lymphocytes generated in vitro and of their immediate progenitors.
Plata R; MacDonald HR; Engers HD
J Immunol; 1976 Jul; 117(1):52-8. PubMed ID: 180182
[TBL] [Abstract][Full Text] [Related]
8. Generation of cytotoxic T lymphocytes in vitro. VI. Effect of cell density on response in mixed leukocyte cultures.
Fitch FW; Engers HD; MacDonald HR; Cerottini JC; Brunner KT
J Immunol; 1975 Dec; 115(6):1688-94. PubMed ID: 127012
[TBL] [Abstract][Full Text] [Related]
9. Studies on the cytolytic attack mechanism of the cytotoxic T lymphocyte (CTL): preparation of antisera against cellfree cytosolic extracts of a CTL clone capable of blocking the lethal hit stage of CTL cytolysis and analysis of the cytolytic structure.
Hiserodt JC
J Immunol; 1985 Jul; 135(1):53-62. PubMed ID: 3158707
[TBL] [Abstract][Full Text] [Related]
10. T lymphocyte tolerance and early appearance of virus-induced cell surface antigens in Moloney-murine leukemia virus neonatally injected mice.
Collavo D; Zanovello P; Biasi G; Chieco-Bianchi L
J Immunol; 1981 Jan; 126(1):187-93. PubMed ID: 6969741
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of cytolytic T lymphocyte clones reactive with Moloney leukemia virus-associated antigens by monoclonal antibodies: a direct approach to the study of H-2 restriction.
Weiss A; MacDonald HR; Cerottini JC; Brunner KT
J Immunol; 1981 Feb; 126(2):482-5. PubMed ID: 6450244
[TBL] [Abstract][Full Text] [Related]
12. T cell-mediated immunity to oncornavirus-induced tumors. I. Ly phenotype of precursor and effector cytolytic T lymphocytes.
Leclerc JC; Cantor H
J Immunol; 1980 Feb; 124(2):846-50. PubMed ID: 6243332
[TBL] [Abstract][Full Text] [Related]
13. Immune response to Moloney murine leukemia virus nonviral, tumor-associated antigens fails to provide in vivo tumor protection.
Jiang D; Flyer DC
J Immunol; 1992 Feb; 148(3):974-80. PubMed ID: 1730885
[TBL] [Abstract][Full Text] [Related]
14. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
Sensi M; Orosz CG; Bach FH
J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
[TBL] [Abstract][Full Text] [Related]
15. Increased cytolytic T lymphocyte activity induced by 2-mercaptoethanol in mixed leukocyte cultures: kinetics and possible mechanisms of action.
Harris JW; MacDonald HR; Engers HD; Fitch FW; Cerottini J
J Immunol; 1976 Apr; 116(4):1071-7. PubMed ID: 130425
[TBL] [Abstract][Full Text] [Related]
16. Mobilization of T lymphocytes following cardiac transplantation. Evidence that CD4-positive cells are required for cytotoxic T lymphocyte activation, inflammatory endothelial development, graft infiltration, and acute allograft rejection.
Bishop DK; Shelby J; Eichwald EJ
Transplantation; 1992 Apr; 53(4):849-57. PubMed ID: 1533070
[TBL] [Abstract][Full Text] [Related]
17. Rejection of an IA+ variant line of FBL-3 leukemia by cytotoxic T lymphocytes with CD4+ and CD4-CD8- T cell receptor-alpha beta phenotypes generated in CD8-depleted C57BL/6 mice.
Yoshimura A; Shiku H; Nakayama E
J Immunol; 1993 Jun; 150(11):4900-10. PubMed ID: 8496592
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibody against IFN-gamma inhibits Moloney murine sarcoma virus-specific cytotoxic T lymphocyte differentiation.
Zanovello P; Vallerani E; Biasi G; Landolfo S; Collavo D
J Immunol; 1988 Feb; 140(4):1341-4. PubMed ID: 2830339
[TBL] [Abstract][Full Text] [Related]
19. Recognition of H-2Kb mutant target cells by Moloney virus-specific cytotoxic T lymphocytes from bm13 (H-2Db-mutant) mice. II. Relationship of Kbm3 and Kbm11 in restriction specificities and allodeterminants.
Stukart MJ; Boes J; Melief CJ
J Immunol; 1984 Jul; 133(1):28-32. PubMed ID: 6202783
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of tumor-specific cytotoxic T-lymphocyte responses by transforming growth factor beta 1.
Inge TH; Hoover SK; Susskind BM; Barrett SK; Bear HD
Cancer Res; 1992 Mar; 52(6):1386-92. PubMed ID: 1531782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
